Snehal Shah
Director Técnico/Científico/I+D en OCULIS HOLDING AG .
Perfil
Snehal Shah is currently the President-Research & Development at Oculis Holding AG.
Previously, Dr. Shah worked as a Member-Hisamitsu Group at Noven Pharmaceuticals, Inc. from 2012 to 2017.
Dr. Shah also held the position of SVP, Chief Regulatory & Product Strategy Officer at IVERIC bio, Inc. Dr. Shah holds a doctorate degree from the University of Kansas and an undergraduate degree from Rutgers University- Newark.
Cargos activos de Snehal Shah
| Empresas | Cargo | Inicio |
|---|---|---|
| OCULIS HOLDING AG | Director Técnico/Científico/I+D | 10/04/2024 |
Antiguos cargos conocidos de Snehal Shah.
| Empresas | Cargo | Fin |
|---|---|---|
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Corporate Officer/Principal | 01/01/2017 |
| IVERIC BIO, INC. | Consejero General | - |
Formación de Snehal Shah.
| Rutgers University- Newark | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OCULIS HOLDING AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
- Bolsa de valores
- Insiders
- Snehal Shah
